Knoll Capital Management as of Dec. 31, 2014
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 14 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 87.2 | $222M | 2.2M | 98.72 | |
| Ampio Pharmaceuticals | 4.6 | $12M | 3.4M | 3.43 | |
| Synthetic Biologics | 1.9 | $5.0M | 3.4M | 1.46 | |
| Alcobra | 1.3 | $3.2M | 865k | 3.73 | |
| Newlink Genetics Corporation | 1.2 | $3.1M | 77k | 39.75 | |
| Keryx Biopharmaceuticals | 1.1 | $2.8M | 200k | 14.15 | |
| Bio Blast Pharma | 0.8 | $2.2M | 338k | 6.39 | |
| Advaxis | 0.7 | $1.8M | 225k | 8.01 | |
| Auspex Pharmaceuticals | 0.4 | $1.1M | 20k | 52.50 | |
| Inovio Pharmaceuticals | 0.3 | $754k | 82k | 9.19 | |
| Advaxis Inc. w exp 07/15/201 | 0.2 | $467k | 113k | 4.15 | |
| Galmed Pharmaceuticals | 0.1 | $377k | 65k | 5.80 | |
| Provectus Biopharmaceuticals I (PVCT) | 0.1 | $160k | 200k | 0.80 | |
| Nephrogenex | 0.0 | $41k | 3.1k | 13.35 |
